SCHEMBL811709

SCHEMBL811709

CC12CC3CC(CC(C3)C1(C)C)C2

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN2D O15399 3/20 0.36
GRIN3B O60391 3/20 0.36
GRIN1 Q05586 3/20 0.36
GRIN2A Q12879 3/20 0.36
GRIN2B Q13224 3/20 0.36
GRIN2C Q14957 3/20 0.36
GRIN3A Q8TCU5 3/20 0.36
SLC22A2 O15244 2/20 0.35
LMNA P02545 2/20 0.35
SLC47A1 Q96FL8 2/20 0.35
SLC22A1 O15245 1/20 0.35
TSHR P16473 1/20 0.35
NFKB1 P19838 1/20 0.35
STAT6 P42226 1/20 0.35
SIGMAR1 Q99720 1/20 0.35
POLB P06746 1/20 0.33
THRB P10828 1/20 0.33
BLM P54132 1/20 0.33
PMP22 Q01453 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ammonia Solution, Strong SCHEMBL3787685 0.97 GRIN2D (0.35) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
Bromide SCHEMBL28280728 0.97 GRIN2D (0.35) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
Water SCHEMBL27943536 0.97 GRIN2D (0.35) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
Bromide SCHEMBL28326375 0.95 GRIN2D (0.33) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
Ammonia Solution, Strong SCHEMBL28310363 0.95 GRIN2D (0.33) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
Hydrochloric Acid SCHEMBL28274675 0.95 LMNA (0.36) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
Iodide SCHEMBL529148 0.95 GRIN2D (0.33) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
Ammonia Solution, Strong SCHEMBL528152 0.95 GRIN2D (0.33) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
Fluoride SCHEMBL29040384 0.95 GRIN2D (0.33) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
Ammonia Solution, Strong SCHEMBL28310364 0.95 GRIN2D (0.33) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 138 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109775723-A A kind of pretreated feedstock is preparing the application in SSZ-13 molecular sieve 山东国瓷功能材料股份有限公司 2019-05-21 CN claimed
CN-108529642-A A kind of preparation method of Cu-SSZ-13 molecular sieves 山东泓泰恒瑞新材料有限公司 2018-09-14 CN claimed
CN-106365175-B A kind of method of microwave radiation technology gangue synthesis CHA molecular sieves 天津大学 2018-07-24 CN claimed
CN-108190907-A A kind of SSZ-13 molecular sieves and preparation method thereof 四川润和催化新材料股份有限公司 2018-06-22 CN claimed
CN-106629761-B A kind of synthetic method of the molecular sieves of SSZ 13 上海卓悦化工科技有限公司 2017-11-24 CN claimed
CN-104437616-B Stratiform containing mesopore titanium-silicon molecular sieve catalyst and its preparation method and application 武汉工程大学 2017-10-10 CN claimed
CN-104437616-A Lamellar catalyst containing mesoporous titanium-silicate molecular sieves and preparation method and application of lamellar catalyst WUHAN INST TECHNOLOGY 2015-03-25 CN claimed
EP-0076755-B1 ACYLAMINO-4-AZA-1-ADAMANTANES, PROCESS FOR THEIR PREPARATION AND THEIR THERAPEUTIC USE ETABLISSEMENTS NATIVELLE S.A. (FR) 1988-01-13 EP claimed
EP-0076755-A1 Acylamino-4-aza-1-adamantanes, process for their preparation and their therapeutic use ETABLISSEMENTS NATIVELLE S.A. (FR) 1983-04-13 EP claimed
CN-118731209-A Method for determining maturity of solid asphalt with extremely high thermal evolution degree 中国地质大学(北京) 2024-10-01 CN disclosed
US-20240101499-A1 ZEOLITE CATALYST, PROCESS FOR PREPARATION AND APPLICATION THEREOF COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2024-03-28 US disclosed
CN-116002708-A CHA structure molecular sieve containing phosphorus and rare earth, preparation method and application thereof 中国石油化工股份有限公司 2023-04-25 CN disclosed
CN-111943224-B Preparation method of Cu-SSZ-13 molecular sieve catalyst, obtained product and application 桂林理工大学 2022-11-11 CN disclosed
CN-113387369-B Preparation method of Cu-SSZ-13 molecular sieve 瑞科稀土冶金及功能材料国家工程研究中心有限公司 2022-10-14 CN disclosed
EP-0105584-A1 Perfluorocarbon emulsions and their preparation and use in therapy ADAMANTECH, INC. (US) 1984-04-18 EP disclosed
WO-1984000686-A1 PERFLUOROCARBON EMULSIONS AND THEIR PREPARATION AND USE IN THERAPY SUN TECH INC (US) 1984-03-01 WO disclosed
EP-0076755-A1 Acylamino-4-aza-1-adamantanes, process for their preparation and their therapeutic use ETABLISSEMENTS NATIVELLE S.A. (FR) 1983-04-13 EP disclosed
US-4043927-A Friction or tractive drive containing ethers of adamantanes SUN VENTURES, INC. (US) 1977-08-23 US disclosed
US-4041086-A HYDRAULIC FLUIDS, DIELECTRIC COOLANTS, TRACTION FLUIDS, LUBRICANTS ON SUN VENTURES, INC. (US) 1977-08-09 US disclosed
US-4008251-A TRACTION FLUID ADDITIVES SUN OIL COMPANY, (SUN RESEARCH AND DEVELOPMENT CO.) 1977-02-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240101499-A1 ZEOLITE CATALYST, PROCESS FOR PREPARATION AND APPLICATION THEREOF PICALM, SMARCC2, SAMM50 GRIN2D 2238/4885GRIN3B 2212/4885GRIN1 2987/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.